beta

CBMG

Cellular Biomedicine Group, Inc.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Cellular Biomedicine Group, Inc. is a holding company, which engages in the development of new treatments for cancerous and degenerative diseases utilizing proprietary cell-based technologies. It specializes in immune cell therapy. The company was founded in 2009 and is headquartered in New York, NY.

Market Cap: 256 Million

Primary Exchange: NASDAQ

Website: http://www.cellbiomedgroup.com

Shares Outstanding: 19.4 Million

Float: 10.3 Million

Dividend: (%)

Beta: 0.99503768765581

Sector: Health Technology

Industry: Biotechnology

Ethical Flags

Longest drawdown: 1584 trading days

From: 2015-03-23 To: 2020-06-02

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud